Original document(14 pages)  中文版
    The invention provides a Chinese medicinal preparation for treating megrims and its preparing process, wherein the preparation in the form of dispersible tablet prepared by disintegrating rhizoma Gastrodiae and mixing with right amount of auxiliary materials. The tablet has the advantages of shorter disintegration time, fast medicament dissolving, quick absorption, high biological availability, convenience in production, carrying and transportation, and stable quality.
Application Number
申请号		 200510200577 Application Date
申请日		 2005.09.29
Title 名称 Chinese medicinal preparation for treating diziness and preparation process thereof
Publication Number
公开号		 1799611 Publication Date
公开日		 2006.07.12
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K36/8988,A61K9/20,A61P1/08
Applicant(s) Name
申请人		 Zhejiang Dade Pharmaceutical Co., Ltd.
Address 地址 322000
Inventor(s) Name 发明人 Chen Fagui
Attorney & Agent 代理人 guo fang

  
Azithromycin enteric casing preparation and its preparing process
Compound Astragalus mongholicus drop pellets and preparation
Iron-sheet dendrobe compound drop pellets and their preparation
Composite cottonrose hibiscus and mongolia bark drop pellets and their preparation
Composite dripping pills of 'Huoxiang Zhengqi' formulation and its preparation method
Ginkago leaf oral disintegrating tablet, and its preparing and quality control method
Compound oral disintegrating tablet of root of red-rooted salvia, and its preparing method and quality control method
Azitromycin particle and method for preparing its enteric coated formulation
Medicine prepn for treating laryngopharyngitis and its prepn
Capsule for treating gynecological diseases and preparation method and quality-control method
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.